CRYPTIGEN
LIVE

Serial Number

98426854

Owner

Epitopea Limited

Attorney

Scott D. Locke

Filing Date

Feb 29, 2024

Add to watchlist:

No watchlists yet
View on USPTO

CRYPTIGEN Trademark

Serial Number: 98426854 • Registration: 7873872

CRYPTIGEN is a trademark filed by Epitopea Limited on February 29, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Epitopea Limited (2 trademarks)

Salisbury House, Station Road
Cambridge 13354764 , GB

Entity Type: 16

Trademark Details

Filing Date

February 29, 2024

Registration Date

July 29, 2025

Published for Opposition

December 3, 2024

Goods & Services

Pharmaceutical, medical or veterinary preparations and substances for the treatment of cancer and diseases of the immune system; Pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; Compounds for treating cancer; Biopharmaceuticals for the treatment of cancer; Pharmaceutical preparations for the prevention of cancer and diseases of the immune system for use in the fields of medicine, health, oncology, immunology; biological compounds or preparations for the treatment of cancer and diseases of the immune system; Therapeutic preparations for the treatment of cancer and diseases of the immune system; Genetic markers for therapeutic or diagnostic use; Cells for medical use; pharmaceutical preparations for the prevention or treatment of tumors; Pharmaceutical preparations for activating cellular function; Cell growth media for growing cells for medical use; Cellular function activating agents for medical purposes; Reconstituted cells for medical treatments; Preparations for detecting genetic predispositions for medical purposes; Pharmaceutical preparations for the prevention or treatment of immune system related diseases and disorders; Immunomodulators; Immunostimulants; Pharmaceutical preparations for immunity adjustment; Immunoassay reagents for medical use; Immunotherapeutic agents for use in treating bacterial infections; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Vaccines; Tumor antigens for medical use; antigens for medical use; viral antigens for medical use; endogenous antigens for medical use; exogenous antigens for medical use; Biological compounds for use in the targeted pharmaceutical therapies; Proteins with diagnostic and therapeutic uses for medical use; Proteins for medical use; Diagnostic reagents for medical use; Reagents and substances for use in testing for medical purposes; Diagnostic and testing preparations for clinical, medical and medical laboratory use; Diagnostic and testing apparatus in the field of modulating therapeutics; Biomarkers for medical use; Nucleic acid sequences for medical purposes; Nucleic recombinant acids for medical use; Diagnostic biomarker reagents for medical purposes; diagnostic test kits consisting primarily of peptides, nucleic acids, buffers, and reagents, for medical purposes; Medical diagnostic test strips for use in the field of cancer and diseases of the immune system; Pharmaceutical preparations for the treatment of cancers

Compilation of statistical data relating to medical research for business purposes; Database management; Data processing; Data processing, systematization and management; Data processing services in the field of healthcare; Promoting public awareness of diseases, available medical treatments and disease prevention practices; Promoting public awareness of medical conditions, diagnosis of medical conditions and prevention of medical conditions; Consultancy and advisory services relating to all of the aforesaid services

Cells for scientific or research purposes; chemical substances for use in the manufacture of medicinal and pharmaceutical products; Chemicals, reagents and substances for medical research purposes; Immunoassay reagents, other than for medical or veterinary use; Chemicals for use in immuno-assay testing other than for medical or veterinary use; Immunoassays based on polypeptides for determining immunological profile, other than for medical or veterinary use; Diagnostic preparations and reagents for scientific or research use; Test kits consisting primarily of peptides, nucleic acids, buffers, and reagents for scientific or research use; Nucleic recombinant acids other than for medical or veterinary purposes; Nucleic acid sequencing programs, other than for medical or veterinary use; Chemical reagents for use in oncology research; Reagents for medical research; Diagnostic reagents, other than for medical or veterinary use; Cell culture reagents for scientific and research use; Biological preparations for use in cell cultures other than for medical or veterinary use; Substances for use in genetic probe assay kits, other than for medical or veterinary use; Antibodies for scientific purposes

Scientific research for medical purposes in the area of cancerous diseases; Research and development in the fields of oncology, and immunology; Research and development services in the fields of oncology and immunology research and development; Drug discovery; drug development; Medical and scientific research, namely, conducting clinical trials for others; Research relating to genetics; Research and development in the field of therapeutics; Research and development in the fields of biotechnology, pharmaceuticals, diagnostic preparations, vaccines, medicines, molecular sciences, clinical trials and therapeutics; Scientific laboratory services; Laboratory testing and analysis of materials; Biological research laboratory services; Services of a chemical laboratory; Development of biochemical reagents; Research and development of biological drug delivery platforms; Development of computer software, computing methods and algorithms; Computer programming; Database design; Online database maintenance for others; Design and development of computer software for use with medical technology; Design and development of software for medical diagnostic or veterinary diagnostic purposes; Design and development of computer systems for data input, output, processing, display and storage; technical surveying; Analysis of technical data, namely, oncology and immunology data; Research relating to data processing; Provision of research information and data relating to medical and veterinary research and development; Scientific research in the field of oncology and immunology conducted using databases; Consultancy, information and advisory services relating to all of the aforesaid services

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 29, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 29, 2025 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Jul 10, 2025 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 8, 2025 AITU
NOTICE OF ALLOWANCE CANCELLED
Jan 21, 2025 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Jan 21, 2025 D1BR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 14, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 3, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 3, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 27, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 12, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 7, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 7, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 7, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 17, 2024 GNRN
NON-FINAL ACTION E-MAILED
Sep 17, 2024 GNRT
NON-FINAL ACTION WRITTEN
Sep 17, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 17, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 11, 2024 NWOS
NEW APPLICATION ENTERED
Feb 29, 2024 NWAP